MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
$58,977K
Accrued rent receivable
-$2,789K
Accrued expenses and
other current...
$1,630K
Operating lease
liabilities
$1,485K
Foreign exchange
remeasurement loss (gain)
-$632K
Amortization (accretion) on
invested securities
-$178K
Loss on disposals of
property and equipment
-$2K
Net cash used in
operating activities
$28,206K
Canceled cashflow
$37,487K
Net (decrease)
increase in cash, cash...
$2,939K
Canceled cashflow
$25,267K
Impairment of property,
plant and equipment
-$16,569K
something is missing
-$9,839K
Stock-based compensation
-$6,102K
Prepaid expenses and
other current assets
$3,407K
Depreciation
-$510K
Non-cash interest
expense
-$405K
Other long-term
assets
$265K
Accounts payable
-$247K
Non-cash lease expense
-$143K
Purchase of marketable
securities
-$61,148K
something is missing
$10,000K
Loan agreement
closing costs
-$172K
Net cash (used in)
provided by investing...
-$17,975K
Net cash provided by
financing activities
-$7,292K
Canceled cashflow
$71,148K
Canceled cashflow
$172K
Maturities of marketable
securities
-$88,700K
something is missing
-$6,611K
Proceeds from exercise of
stock options
-$853K
Cash received from
held for sale assets
-$423K
Back
Back
Cash Flow
Instil Bio, Inc. (TIL)
Instil Bio, Inc. (TIL)
source: myfinsight.com